Application of platelet-rich plasma in surgical treatment of rotator cuff tears

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045039

Enrollment

Unknown

Registered

2021-04-03

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator cuff tear

Interventions

Lr-PRP group:Intraoperative injection of Lr- PRP (2-3mL)

Lp-PRP group:Intraoperative injection of Lp-PRP (2-3mL)

Control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients with full-thickness rotator cuff tear or Elman III partial tear who underwent arthroscopic surgery; 2.Patients with double row rotator cuff suture repair; 3.Age 18-65 years old.

Exclusion criteria

Exclusion criteria: 1.Huge rotator cuff tear; 2.Combined with clear shoulder stiffness; 3.Severe fracture and osteoporosis; 4.Smokers; 5.Immune system diseases; 6.Blood system diseases; 7.Tumor patients; 8.Poor compliance, etc..

Design outcomes

Primary

Measure	Time frame
Ordinary mri of shoulder joint;Pain;Shoulder function;Shoulder function;	—

Countries

China

Contacts

Public ContactTang Xin

West China Hospital Clinical Medical College, Sichuan University

Tangxin9388@163.com+86 18980606327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026